Tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs

Min Liu, Qin Pan, Fengling Luo, Craig Meyers, Xiao Lian Zhang

Research output: Contribution to journalArticle

Abstract

Certain carbohydrate antigens of malignantly transformed cells have been identified as markers for the onset of cancer and have become targets for the development of anticancer vaccine therapies. For tumor antigens, many carbohydrate antigens belong to T-independent (TI) antigens. Carbohydrate conjugated to protein carriers can switch TI antigen to a T-dependent (TD) antigen. Attempts to add an innate immune response element (such as Toll-like receptor ligand) to carbohydrate TI-antigens have also been studied. Glycosylation inhibitors or small interfering RNA have also been used for antitumor and/or antiviral agents. This review aims at describing the vast spectrum of tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalWuhan University Journal of Natural Sciences
Volume18
Issue number1
DOIs
StatePublished - Feb 11 2013

Fingerprint

Cancer Vaccines
Neoplasm Antigens
T Independent Antigens
Carbohydrates
Pharmaceutical Preparations
Antigens
Active Immunotherapy
Toll-Like Receptors
Viral Tumor Antigens
Response Elements
Glycosylation
Innate Immunity
Antineoplastic Agents
Small Interfering RNA
Antiviral Agents
Carrier Proteins
Ligands
Neoplasms

All Science Journal Classification (ASJC) codes

  • General

Cite this

Liu, Min ; Pan, Qin ; Luo, Fengling ; Meyers, Craig ; Zhang, Xiao Lian. / Tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs. In: Wuhan University Journal of Natural Sciences. 2013 ; Vol. 18, No. 1. pp. 1-8.
@article{6d0bdbece12848608d5a6bebb817f3b0,
title = "Tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs",
abstract = "Certain carbohydrate antigens of malignantly transformed cells have been identified as markers for the onset of cancer and have become targets for the development of anticancer vaccine therapies. For tumor antigens, many carbohydrate antigens belong to T-independent (TI) antigens. Carbohydrate conjugated to protein carriers can switch TI antigen to a T-dependent (TD) antigen. Attempts to add an innate immune response element (such as Toll-like receptor ligand) to carbohydrate TI-antigens have also been studied. Glycosylation inhibitors or small interfering RNA have also been used for antitumor and/or antiviral agents. This review aims at describing the vast spectrum of tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs.",
author = "Min Liu and Qin Pan and Fengling Luo and Craig Meyers and Zhang, {Xiao Lian}",
year = "2013",
month = "2",
day = "11",
doi = "10.1007/s11859-013-0885-0",
language = "English (US)",
volume = "18",
pages = "1--8",
journal = "Wuhan University Journal of Natural Sciences",
issn = "1007-1202",
publisher = "Wuhan University",
number = "1",

}

Tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs. / Liu, Min; Pan, Qin; Luo, Fengling; Meyers, Craig; Zhang, Xiao Lian.

In: Wuhan University Journal of Natural Sciences, Vol. 18, No. 1, 11.02.2013, p. 1-8.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs

AU - Liu, Min

AU - Pan, Qin

AU - Luo, Fengling

AU - Meyers, Craig

AU - Zhang, Xiao Lian

PY - 2013/2/11

Y1 - 2013/2/11

N2 - Certain carbohydrate antigens of malignantly transformed cells have been identified as markers for the onset of cancer and have become targets for the development of anticancer vaccine therapies. For tumor antigens, many carbohydrate antigens belong to T-independent (TI) antigens. Carbohydrate conjugated to protein carriers can switch TI antigen to a T-dependent (TD) antigen. Attempts to add an innate immune response element (such as Toll-like receptor ligand) to carbohydrate TI-antigens have also been studied. Glycosylation inhibitors or small interfering RNA have also been used for antitumor and/or antiviral agents. This review aims at describing the vast spectrum of tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs.

AB - Certain carbohydrate antigens of malignantly transformed cells have been identified as markers for the onset of cancer and have become targets for the development of anticancer vaccine therapies. For tumor antigens, many carbohydrate antigens belong to T-independent (TI) antigens. Carbohydrate conjugated to protein carriers can switch TI antigen to a T-dependent (TD) antigen. Attempts to add an innate immune response element (such as Toll-like receptor ligand) to carbohydrate TI-antigens have also been studied. Glycosylation inhibitors or small interfering RNA have also been used for antitumor and/or antiviral agents. This review aims at describing the vast spectrum of tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs.

UR - http://www.scopus.com/inward/record.url?scp=84873345705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873345705&partnerID=8YFLogxK

U2 - 10.1007/s11859-013-0885-0

DO - 10.1007/s11859-013-0885-0

M3 - Article

AN - SCOPUS:84873345705

VL - 18

SP - 1

EP - 8

JO - Wuhan University Journal of Natural Sciences

JF - Wuhan University Journal of Natural Sciences

SN - 1007-1202

IS - 1

ER -